Vistagen Therapeutics (VTGN) Exchange Rate Effect (2015)
Vistagen Therapeutics' (VTGN) quarterly Exchange Rate Effect came in at $10300.0 in Q2 2015.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Exchange Rate Effect (2015) Analysis & Trends
Vistagen Therapeutics has disclosed Exchange Rate Effect across 1 years of filings, most recently posting $10300.0 for Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.09 Bn | 193.10 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.68 Bn | 176.50 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.39 Bn | 123.54 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.79 Bn | 73.79 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.35 Bn | 48.21 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.40 Bn | 30.10 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.66 Bn | 30.38 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn | 315,000.00 |
| 10 | Vistagen Therapeutics | 10.26 Mn | 10.26 Mn | - | - |